WIN-Partners Co., Ltd. (TYO:3183)

Japan flag Japan · Delayed Price · Currency is JPY
1,422.00
-11.00 (-0.77%)
Feb 16, 2026, 3:30 PM JST
Market Cap39.44B +5.5%
Revenue (ttm)87.25B +5.6%
Net Income2.14B +4.4%
EPS75.89 +6.0%
Shares Out27.77M
PE Ratio18.71
Forward PEn/a
Dividend53.00 (3.70%)
Ex-Dividend DateMar 30, 2026
Volume35,300
Average Volume24,715
Open1,444.00
Previous Close1,433.00
Day's Range1,420.00 - 1,454.00
52-Week Range1,125.00 - 1,595.00
Beta0.08
RSI69.11
Earnings DateFeb 9, 2026

About WIN-Partners

WIN-Partners Co., Ltd., through its subsidiaries, distributes medical devices to medical institutions primarily in Japan. The company offers percutaneous coronary intervention products, including PTCA balloon catheters, drug-eluting stents, and intravascular ultrasound catheters; pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators, and ablation catheters; and stent grafts, transcatheter heart valves, and mechanical heart valves. It also provides peripheral vascular stents, carotid artery stents,... [Read more]

Sector Healthcare
Founded 1983
Employees 630
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 3183
Full Company Profile

Financial Performance

In fiscal year 2025, WIN-Partners's revenue was 81.41 billion, an increase of 5.64% compared to the previous year's 77.06 billion. Earnings were 2.02 billion, an increase of 10.03%.

Financial Statements